Forest Laboratories Commences Tender Offer for Shares and Certain Notes and Warrants of Clinical Data, Inc.

Forest Laboratories, Inc. FRX today announced the commencement of a tender offer by its indirect wholly-owned subsidiary, Magnolia Acquisition Corp., for all outstanding shares of common stock, $0.01 par value, of Clinical Data, Inc. CLDA for $30.00 per share in cash plus contingent consideration of up to $6.00 per share that may be paid pursuant to the terms of a Contingent Value Agreement to be entered into by Forest, FL Holding CV, an indirect wholly-owned subsidiary of Forest, and Magnolia for the benefit of tendering security holders based upon achievement of certain milestones related to Viibryd™, and for certain outstanding notes and warrants issued by Clinical Data that are convertible into or exerciseable for shares of Clinical Data's common stock for the consideration described below.

The tender offer is being made pursuant to an Offer to Purchase, dated March 8, 2011, and in connection with the previously announced Agreement and Plan of Merger, dated February 22, 2011, by and among Forest, FL Holding CV, Magnolia, and Clinical Data.